As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Bristol Myers Squibb supports and complies fully with the EFPIA Disclosure Code for payments made to healthcare professionals (HCPs) and Healthcare Organisations (HCOs). Our collaboration with the healthcare community is an important and necessary aspect of bringing innovative medicines to patients and ensuring understanding of the safe and appropriate use of our medicines for the benefit of patients.

For more information, please visit the Irish Pharmaceutical Health Association website.

Date of preparation: February 2021